Within the context of breast cancer, subtype specific expression of BCAT enzymes has been observed with the cytosolic isoform BCAT1 commonly expressed in breast tumors that lack estrogen receptor or ER-activity, including progressive HR+ tumors that have lost estrogen dependency [121,122]. This evidence concerns the gene BCAT1 and breast carcinoma.